Kingworld Medicines Group Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kingworld Medicines Group Limited with three other
companies in this sector in China:
Tibet Rhodiola Pharmaceutical Holding Company
sales of 796.77 million Chinese Renmimbi [US$125.77 million]
of which 100%
was Pharmaceutical Manufacturing Industry),
GuangYuYuan Chinese Herbal Medicine Co Ltd
(933.68 million Chinese Renmimbi [US$147.38 million]
of which 15%
was Drug Industry), and
China NT Pharma Group Co Ltd
(915.12 million Chinese Renmimbi [US$144.45 million]
of which 62%
was Third-party Pharmaceutical Promotion & S).
Kingworld Medicines Group Limited reported sales of 1.05 billion Chinese Renmimbi (US$166.30 million)
December of 2016.
increase of 47.6%
versus 2015, when the company's sales were 713.55 million Chinese Renmimbi.
This was the third consecutive year of growth at Kingworld Medicines Group Limited.